SAN ANTONIO, Oct. 9, 2012 /PRNewswire/ -- Bio-Solutions Corp (OTCQB: BISU) (PINKSHEETS: BISU) is pleased to announce that the company has recently acquired Type2 Defense. Type2 Defense is a high antioxidant and glucose control dietary supplement powder. This Proprietary, High-antioxidant formula is packaged with 30 packets to a box. Type2 Defense powder drink mix delivery system has been developed to support healthy glucose levels for Type 2 Diabetics and Pre-Diabetics. Bio-Solutions Corp, a NV Corp, has recently relocated Headquarters, from Montreal Canada to San Antonio TX. The company has also recently replaced all prior Management and Directors.

BOSS Creative of San Antonio TX, has officially been retained, to begin the online identity transformation of Bio-Solutions Corp. BOSS Creative, is a Professional Multidisciplinary Design-Technology Firm, Specializing in Web Development, Brand Identity and SEO product placement advertizing. "As BOSS begins to build our SEO, Website and Online presence, we will look to generate online sales in addition to the few sample markets that we are currently working with. Ideally, over time all sales will come from re-occurring online sales orders. We are very excited to be able to engage the professional team at BOSS, who have a huge online presence," stated Bill Gallagher, CEO/CFO.

There is an Estimated 100 plus Million Americans at risk of diabetes in the following order: Data from the 2011 National Diabetes Fact Sheet (released Jan. 26, 2011) Total prevalence of diabetes Total: 25.8 million children and adults in the United States -- 8.3% of the population -- have diabetes. Diagnosed: 18.8 million people Undiagnosed: 7.0 million people Pre-diabetes: 79 million people*

New Cases: 1.9 million new cases of Diabetes were diagnosed in people aged 20 years and older in 2010. Given the two types of Diabetes (Type 1 and Type 2), Type2 Defense will obviously cater to Types 2 patients, which are 90% of all Diabetics. Type2 Defense will help to maintain healthy blood glucose levels.

Operations are now fully managed in San Antonio, TX. Research and Development is managed by Former Nestle's SA Nutritional Food Chief Scientist, Mr. Sekhar Mallangi.

According to Dailyfinance.com (1/27/11 Big Pharma Article): "In 2009, the U.S. diabetes market grew 17% from 2008, reaching $14.9 billion, according to data from health care information company IMS Health. Worldwide, the market generated sales of over $25 Billion." By 2019, Morningstar projects the worldwide Diabetes market, excluding insulin, will grow to over $55 billion.

We believe that there is a growing market place that lacks adequate healthy tools to maintain healthy blood glucose levels. Type2 Defense is a powder blend of natural ingredients that has been developed to help support healthy blood glucose levels. The Type2 Defense powder blend is a flavorful supplement when mixed with water becomes an effective vehicle that encourages sustainable healthy habits. A convenient and all natural pure health beverage containing green tea blended with cinnamon and blueberry flavors and the Type2 Defense proprietary blend. The Product's goal is to provide a safe and natural supplement that will assist in the stabilization of healthy glucose levels.

Finally, we would also like to make our shareholders aware that, we have actively been speaking with the likes of former NFL Players, to be our Celebrity Spokesperson for Type2 Defense. "This is a very exciting time, where a lot of new change is underway," stated CEO/ CFO William Gallagher.

Forward-Looking Statements

This press release contains forward-looking statements made pursuant to the safe harbor provisions of the U.S. Securities Litigation Reform Act of 1995. Forward-looking statements involve known and unknown risks and uncertainties, which could cause the Bio-Solutions actual results to differ materially from those in the forward-looking statements. Investors are cautioned not to rely on these forward-looking statements. The Company does not undertake to update these forward-looking statements and disclaims any obligation to update any such factors or to publicly announce the result of any revisions to any of the forward-looking statements contained herein to reflect future results, events or developments, except if we are requested by a governmental authority or applicable law.